Nearly 8,000 cardiac panel blood tests have been recalled after 41 reports of inaccurate test results that pose the risk of missing a heart attack diagnosis, the FDA said July 17. Quidel ...

Please provide your email address to receive an email when new articles are posted on . Certain blood tests have been recalled due to risk for false negative or falsely low cardiac troponin levels.

Please provide your email address to receive an email when new articles are posted on . A serum protein panel predicted risk for cardiac toxicity among childhood cancer survivors exposed to ...

The FDA convened a committee of advisers to assess a cardiac device made by Abbott, but the agency did not disclose that 10 of the 14 members had received payments from the company or conducted ...